1. The effects of starvation and diabetes on brain fuel metabolism were examined by measuring arteriovenous differences for glucose, lactate, acetoacetate and 3-hydroxybutyrate across the brains of anaesthetized fed, starved and diabetic rats. 2. In fed animals glucose represented the sole oxidative fuel of the brain. 3. After 48h of starvation, ketonebody concentrations were about 2mM and ketone-body uptake accounted for 25 % of the calculated 02 consumption: the arteriovenous difference for glucose was not diminished, but lactate release was increased, suggesting inhibition of pyruvate oxidation. 4. In severe diabetic ketosis, induced by either streptozotocin or phlorrhizin (total blood ketone bodies >7mM), the uptake of ketone bodies was further increased and accounted for 45 % of the brain's oxidative metabolism, and the arteriovenous difference for glucose was decreased by one-third. The arteriovenous difference for lactate was increased significantly in the phlorrhizin-treated rats. 5. Infusion of 3-hydroxybutyrate into starved rats caused marked increases in the arteriovenous differences for lactate and both ketone bodies. 6. To study the mechanisms of these changes, steady-state concentrations of intermediates and cofactors of the glycolytic pathway were determined in freeze-blown brain. 7. Starved rats had increased concentrations of acetyl-CoA. 8. Rats with diabetic ketosis had increased concentrations of fructose 6-phosphate and decreased concentrations of fructose 1,6-diphosphate, indicating an inhibition of phosphofructokinase. 9. The concentrations of acetyl-CoA, glycogen and citrate, a potent inhibitor of phosphofructokinase, were increased in the streptozotocin-treated rats. 10. The data suggest that cerebral glucose uptake is decreased in diabetic ketoacidosis owing to inhibition of phosphofructokinase as a result of the increase in brain citrate. 11. The inhibition of brain pyruvate oxidation in starvation and diabetes can be related to the accelerated rate ofketone-body metabolism; however, we found no correlation between the decrease in glucose uptake in the diabetic state and the arteriovenous difference for ketone bodies. 12. The data also suggest that the rates of acetoacetate and 3-hydroxybutyrate utilization by brain are governed by their concentrations in plasma. 13. The finding of very low concentrations of acetoacetate and 3-hydroxybutyrate in brain compared with plasma suggests that diffusion across the bloodbrain barrier may be the rate-limiting step in their metabolism.
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The studies of Owen et al. (1967) established that the human brain can utilize ketone bodies as a fuel in place ofglucose. In obese patients starved for 40 days, they observed that ketone bodies account for approx. 60% of the fuel needs of brain and that glucose oxidation is decreased to less than one-third of the value in the post-absorptive state. Hawkins et al. (1971) observed that acetoacetate and 3-hydroxybutyrate are also utilized by the brain of the rat during starvation. In these experiments, however, ketonebody metabolism accounted for less than 22 % of the brain's fuel needs, and glucose utilization was not significantly diminished.
The present study was designed to investigate some ofthe factors that determine the relative magnitude of glucose and ketone-body metabolism in brain. For this purpose arteriovenous differences for glucose, lactate, acetoacetate and 3-hydroxybutyrate were determined across the brains of fed and starved rats, rats with diabetic ketoacidosis induced by either phlorrhizin or streptozotocin and rats infused with 3-hydroxybutyrate. To determine the sites at which the metabolism of glucose and ketone bodies is regulated in these situations, brain metabolites were measured in rapidly frozen tissue obtained with the 'freeze-blowing apparatus' devised by Veech et al. (1973) . A preliminary report ofthis work has appeared (Berger et al., 1973 
Animals
Female rats ofthe Sprague-Dawley strain weighing 180-210g were used. They were maintained on Purina Laboratory Chow for at least 3 days before use. Rats made diabetic with streptozotocin received 150mg of the drug/kg by tail-vein injection. They were allowed free access to food and were killed after 2-3 days. None of the animals was in coma. Phlorrhizin (40mg in 0.1 ml of propylene glycol) was administered subcutaneously to rats starved for 24h. The animals received four doses of phlorrhizin 6h apart, and were killed 3-5h after the final dose. The degree of hyperketonaemia produced by this regimen was comparable with that caused by streptozotocin (see Table 1 ); however, the phlorrhizin-treated animals did not appear ill.
Collection of blood samples
Rats were anaesthetized with an intraperitoneal injection of pentobarbital. A dose of 40-50mg/kg was used for all animals except those with streptozotocin-diabetes, which required only 30-40mg/kg. The procedure used for collecting arterial and cerebral venous blood was essentially that described by Hawkins et al. (1971) . Blood samples were deproteinized in 10% (w/v) HC104, centrifuged, and the supernatant was neutralized with KHCO3.
Infusion studies
In some experiments 3-hydroxybutyrate was infused through a polyethylene catheter (internal diam. 0.58mm; external diam. 0.965mm; type PE50; Clay-Adams) that had been passed into the inferior vena cava through an incision in a femoral vein. Sodium DL-3-hydroxybutyrate (3M), pH8.9, was infused for 10min at a rate of 120tmol/min (2.4ml/h) and then for an additional 20min at a rate of 6OtLmol/ min (1.2ml/h). A stable arterial concentration of 3-hydroxybutyrate was attained by 20min of infusion. In another series of experiments sodium acetoacetate was infused into the rats for 60-90min in the same manner as DL-3-hydroxybutyrate, but at half the rate.
Tissue studies
The brains of a group of rats were freeze-blown by using the apparatus devised by Veech et al. (1973) . Arteriovenous differences across the brain were not determined in these rats; however, the rats were anaesthetized with pentobarbital for approx. 20min before the tissue was obtained, in order to mimic the conditions of the other animals. Samples of blood were obtained from the tail vein or from the abdominal aorta immediately before freeze-blowing, in order to determine the blood/brain ratio of certain metabolites.
Analyses
Frozen brain tissue was powdered under liquid N2 in a mortar and deproteinized and neutralized by a modification of the procedure described by Nelson et al. (1971) . The extract was analysed spectrophotometrically for glucose (Slein, 1963) , acetoacetate and 3-hydroxybutyrate (Williamson et al., 1962) , glucose 6-phosphate and fructose 6-phosphate (Hohorst, 1963a) , ATP (Lamprecht & Trautschold, 1963) , ADP and AMP (Adam, 1963) , creatine phosphate (Lamprecht & Stein, 1963) and citrate (Start & Newsholme, 1968) by standard enzymic methods. Fructose 1,6-diphosphate was assayed fluorimetrically as described by Williamson & Corkey (1969) . Acetyl-CoA was assayed fluorimetrically by coupling acetyl-CoA disappearance during citrate synthesis to the malate dehydrogenase reaction (Williamson & Corkey, 1969) . The results were corrected for conversion of oxaloacetate into malate. Tissue was prepared for glycogen determination as described by Good et al. (1933) . Glucose present as glycogen was determined in the neutralized acid hydrolysate by the glucose oxidase method (Huggett & Nixon, 1957) as modified by Krebs et al. (1964) . Neutralized blood extracts were analysed for glucose, acetoacetate and 3-hydroxybutyrate, and lactate (Hohorst, 1963b) .
Enzyme nomenclature
The following enzymes are referred to in the text: hexokinase (EC 2.7.1.1); phosphofructokinase (EC 2.7.1.11); pyruvate dehydrogenase (EC 1.2.4.1); glycogen synthetase (glycogen-UDP glucosyltransferase) (EC 2.4.1.11); creatine kinase (EC 2.7.3.2); 3-hydroxybutyrate dehydrogenase (EC 1.1.1.30); 3-oxo acid CoA-transferase (EC 2.8.3.5) .
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Results
The fuel metabolism of brain was assessed on the basis of arteriovenous differences for glucose, acetoacetate, 3-hydroxybutyrate and lactate. In order to calculate the arteriovenous difference for 02, it was assumed that all the ketone bodies taken up were completely oxidized, as was all the glucose not released as lactate. The validity of this assumption is borne out by studies in both man (Owen et al., 1967; Gottstein et al., 1971) and rat (Hawkins et al., 1971) , in which it was demonstrated that the arteriovenous difference for 02, calculated in this way, is very close to the measured arteriovenous difference across the brain.
Fuel metabolism in fed and starved rats
The arterial concentrations of glucose, lactate, acetoacetate and 3-hydroxybutyrate in all of the groups studied are presented in Table 1 and the arteriovenous differences for these substances in Table 2 . In agreement with earlier studies in man (Himwich, 1951) and in the rat (Hawkins et al., 1971) , glucose was essentially the sole fuel of brain in the fed state and lactate release was negligible (Table 2 ). In rats starved for 24 and 48 h the concentrations of acetoacetate and 3-hydroxybutyrate in blood were substantially higher and there were significant arteriovenous differences for these ketone bodies across the brain. Here, ketone bodies accounted for 20-25 % of the calculated 02 consumption of the brain. The arteriovenous differences for glucose and for 02 consumption attributable to glucose oxidation were somewhat less than in fed rats; however, the differences were not statistically significant (see the Discussion section).
Fuel metabolism in diabetic rats
In rats with streptozotocin-diabetes, the concentrations of acetoacetate+3-hydroxybutyrate and of glucose were increased to 8.5 and 23mM respectively (Table 1 ). The arteriovenous difference for acetoacetate was approximately 3 times that of the two groups of starved rats and the difference for 3-hydroxybutyrate was 1.5 times as much (Table 2) . Together, the two ketone bodies accounted for 52 % of the calculated 02 consumed by brain. In comparison with fed rats, the contribution of glucose to the calculated 02 consumption was significantly diminished.
Rats treated with phlorrhizin achieved the same degree of hyperketonaemia and had approximately the same arteriovenous differences for acetoacetate and 3-hydroxybutyrate as did the rats treated with streptozotocin. The arteriovenous differences for glucose were also comparable in the two groups despite the 10-fold greater glucose concentration in the streptozotocin-treated animals. Likewise, the contribution ofglucose to the calculated 02 consumption was significantly depressed in the phlorrhizintreated group, although here it was due to a combination of a decreased arteriovenous difference for glucose and an increased glucose conversion into lactate.
Infusion of 3-hydroxybutyrate
When sodium DL-3-hydroxybutyrate was infused into rats starved for 24 h,the arterial concentrationsof 3-hydroxybutyrate and acetoacetate increased to 5.23 and 1.01mm respectively (Table 1 ) and the 3-hydroxybutyrate/acetoacetate ratio increased to 4.8 (see Table 1 ). The arteriovenous difference for 3-hydroxybutyrate of 0.29mM (Table 2) was 3 times that observed in starved rats and twice that in rats with streptozotocin-diabetes. Glucose uptake was not significantly diminished by 3-hydroxybutyrate; however, the arteriovenous difference for lactate increased markedly from 0.12 to 0.37mM. As a result, the calculated value for 02 required for glucose oxidation decreased to 1.2mM, about half the value found in 24h-starved animals, and glucose oxidation accounted for only 40 % of calculated 02 consumption.
In another series of experiments sodium acetoacetate was infused in place of DL-3-hydroxybutyrate (for 60-90min rather than 30min, however). The findings were very similar to those of Hawkins et al. (1971) , namely, a very large increase in the arteriovenous difference for acetoacetate with no significant change in the arteriovenous difference for either glucose or lactate. Evaluation of the creatine kinase equilibrium in brain (see below) indicated that sodium acetoacetate probably caused an increase in brain pH.
Since this would increase the activity of phosphofructokinase (Trivedi & Danforth, 1966) and since the effect of acetoacetate on the redox state of brain was not evaluated the results are not presented.
Lactate release and ketone-body uptake In general the arteriovenous difference for lactate was greater when the brain obtained a greater percentage ofits fuel from ketone bodies (Table 2) . Thus, fed animals, which used very little acetoacetate and 3-hydroxybutyrate, had a small net release of lactate (0.02mM), whereas rats starved for 24 and 48h and rats treated with phlorrhizin had arteriovenous differences for lactate of 0.12, 0.18 and 0.24mM respectively. Rats infused with 3-hydroxybutyrate derived a larger percentage of their calculated 02 consumption from ketone-body oxidation than did any other group and also demonstrated the largest arteriovenous difference for lactate (0.37mM). The possibility that part ofthis increment in lactate release was due to a change in the redox state of the brain was not evaluated; however, Miller and co-workers have not found an appreciable increase in the lactate/ Rats with streptozotocin-diabetes were the exception to the trend. The arteriovenous difference for lactate in these animals was only 0.12mM despite the very large arteriovenous difference for ketone bodies in this group. Although the arteriovenous difference for lactate was 6-fold greater than that of the fed rats the difference was not significant (0.1 >P>0.05).
Glucose and ketone-body uptake Although the arteriovenous difference for glucose tended to be greater and the difference for ketonebodies smaller in fed and starved rats than in the diabetic groups, the negative correlation was not statistically significant when all the data were pooled (r = -0.002).
Concentration and uptake ofketone bodies In agreement with earlier studies (Daniel et al., 1971; Hawkins et al., 1971) , the arteriovenous difference for acetoacetate across the rat brain was Vol. 138 approximately proportional to its arterial concentration (r = 0.71, P<0.001, n = 54). The relationship between the arterial concentration of 3-hydroxybutyrate and its removal by brain was more complex. Although the arteriovenous difference for 3-hydroxybutyrate was also proportional to its concentration, the correlation was not as close as for acetoacetate (r = 0.52, P<0.001, n = 54) because of the relatively small arteriovenous differences in the two groups of diabetic rats. For instance, the arteriovenous difference for 3-hydroxybutyrate was only slightly greater in the streptozotocin-and phlorrhizin-treated rats than in starved rats, even though their arterial concentrations of 3-hydroxybutyrate were 3-8-fold higher. Likewise, the rats infused with 3-hydroxybutyrate had a lower arterial concentration of 3-hydroxybutyrate than did the diabetic animals, but had a more than 2-fold greater arteriovenous difference.
Brain metabolites
Brains were obtained from separate groups of fed, 48 h-starved and diabetic rats for the assay ofmetabolites. The blood concentrations of glucose, acetoacetate and 3-hydroxybutyrate in these rats and the rats used for determining arteriovenous differences were comparable (see Tables 5 and 6 ).
Hexose phosphates. As shown in Table 3 , the concentrations of the hexose monophosphates and fructose 1,6-diphosphate in brain were not altered by 48h ofstarvation; however, glucose 6-phosphate and fructose 6-phosphate were significantly increased and fructose 1,6-diphosphate was decreased in rats with diabetic ketoacidosis induced by streptozotocin. The fact that fructose-6-phosphate is increased indicates that the block in cerebral glycolysis in these animals is at the level ofphosphofructokinase. Similar changes in the concentrations of hexose phosphates were noted in the brains of rats with phlorrhizin-diabetes. Here, the concentrations of both glucose 6-phosphate and fructose 6-phosphate, although elevated, were not significantly higher than in fed rats (P<0.1). Fructose 6-phosphate was significantly higher than in starved animals, and the concentration of fructose 1,6-diphosphate and the mass-action ratio of phosphofructokinase (see Table 3 ) were both significantly diminished.
Citrate. The regulation of phosphofructokinase is very complex. In addition to the fact that the enzyme has several molecular forms, it is strongly inhibited by one of its substrates, ATP, by citrate and by an increase in [H+] : this inhibition can be counteracted by a variety of substances including fructose 6-phosphate, fructose 1,6-diphosphate, 5'-AMP, Pi and 3':5'-cyclic AMP, and by a decrease in [H+l (reviewed by Mansour, 1972 (Table 3) . These increases in citrate are smaller than those associated with inhibition of phosphofructokinase in heart muscle perfused with free fatty acids or ketone bodies; however, phosphofructokinase was probably less completely inhibited in the present study (see Randle et al., 1966) .
Acetyl-CoA. Increases in the concentrations of citrate in heart muscle of diabetic rats have been attributed to an increase in the acetyl-CoA/CoA ratio due to an accelerated rate of ketone-body and free fatty acid oxidation (Randle et al., 1966) . In the present study, the concentration of acetyl-CoA was increased in the brains ofanimals with streptozotocindiabetes when compared with fed animals ( Table 3 ). The numbers of determinations of acetyl-CoA in the other groups were too few to allow statistical comparison; nevertheless, it is noteworthy that the individual values for acetyl-CoA in starved rats were comparable with those of animals treated with streptozotocin and were 2S.D. or more greater than the mean value in the fed group. The concentration offree CoA was not determined.
Adenine nucleotides (Table 3) . In general the concentrations of adenine nucleotides differed very little from one group to another, suggesting that they played little or no role in the decrease in phosphofructokinase activity seen in diabetes. The concentration ofAMP was slightly higher in starved than in fed rats: the changes were small, however, and the fed and starved rats did not differ with respect to arteriovenous difference for glucose uptake or the massaction ratio of phosphofructokinase (Table 3) . A small but significant increase in ATP was also noted in rats with streptozotocin-diabetes.
Creatine phosphate. As shown in Table 4 (Lowry & Passoneau, 1964; Siesjo et al., 1972) . The fact that the equilibrium ratio did not vary is noteworthy, since the complete equilibrium expression for creatine kinase (Kuby & Noltmann, 1962) Glucose in blood and brain. A change in the distribution of glucose between blood and brain could theoretically be due to alterations in either the bloodbrain barrier for glucose, the permeability of brain cells to glucose, or the activity of hexokinase. A small but significant increase in the brain/blood ratio for glucose was noted after 48 h ofstarvation (Table 5 ). The meaning of this change is not clear, since the arteriovenous difference for glucose across the brain was not significantly decreased. An increase in the brain/blood ratio for glucose, of a comparable magnitude, was also noted in rats with diabetes induced by streptozotocin. Here a decrease in hexokinase activity caused by inhibition by glucose 6-phosphate may have been a factor, although it remains to be determined (12) 5.6± 0.4 (8) 3808± 319 (10) 6.0±1.0 (10) 4044±178 (9) 5.8±0.5 (9) 3781± 33(6) 5.9±1.0 (6) 1974 Table 5 . Concentrations ofglucose in blood and brain Results are means±s.E.M. with numbers of observations in parentheses. Blood specimens of fed, starved and phlorrhizindiabetic rats were from tail veins; blood specimens of other animals were from the femoral artery. In calculating brain glucose and the brain/blood ratio, no correction was made for that portion of brain glucose present in the vascular space. Values for blood glucose are for whole blood. See legend to Table 3 whether hexokinase activity was decreased for other reasons or whether glucose permeability was altered. The highest brain/blood ratio for glucose was observed in phlorrhizin-treated rats; indeed, the ratio was significantly higher than that of the streptozotocin-treated group, suggesting that phlorrhizin may have had an independent effect on glucose permeability beyond the blood-brain barrier or on hexokinase activity. The relatively high brain/blood ratios for glucose reported in this study are probably due to the use of anaesthetized rats (Nelson et al., 1971; Passoneau et al., 1971) . Glycogen. The concentration of glycogen in brain was not affected by starvation or by phlorrhizindiabetes (Table 3) . On the other hand, in rats with streptozotocin-diabetes, glycogen was substantially increased. This could have been due to the elevated concentration ofglucose 6-phosphate in these animals (0.23mM), as the Ka (glucose 6-phosphate) for brain glycogen synthetase is 0.26mm (Goldberg & O'Toole, 1969) . Another possibility is that glycogen synthetase was secondarily activated by the high concentration of glucose itself (Hers et al., 1970) . If the latter mechanism were operative, it could explain why no increase in brain glycogen was observed in the phlorrhizintreated animals.
Acetoacetate in bloodandbrain. The concentrations of ketone bodies in blood and brain were determined in starved and diabetic rats (Table 6 ). In agreement with earlier findings (Hawkins et al., 1971) , the brain/ blood ratios for acetoacetate and 3-hydroxybutyrate were extremely low. When the concentration ofacetoacetate in whole blood ranged between 2.4 and 2.7mM, the calculated concentration of acetoacetate in the extravascular space of brain was less than 0.1 mi. Thus the concentration of acetoacetate in brain was less than 4 % of that in whole blood and 2.6 % of that in plasma. Since the interstitial space of brain, as determined with inulin, comprises approx. 15 % (Tschirgi, 1960) of its volume, the fact that acetoacetate is distributed in a volume smaller than this suggests that entrance into the interstitial space may be rate-limiting for acetoacetate utilization in brain. Vol. 138
The brain/blood ratio for acetoacetate was highest in starved rats for reasons not understood. Despite this, the calculated concentration of acetoacetate in the extravascular space of brain was higher in rats with diabetes because of their markedly increased blood concentration of acetoacetate.
3-Hydroxybutyrate in blood and brain. The brain/ blood ratio for 3-hydroxybutyrate was about 5-10-fold greater than that for acetoacetate (Table 6 ). This could occur if the blood-brain barrier was more permeable to 3-hydroxybutyrate than to acetoacetate, if the 3-hydroxybutyrate/acetoacetate ratio of the brain cell, as determined by the redox state of brain mitochondria, is lower than the ratio in plasma, or if 3-hydroxybutyrate is utilized at a much slower rate than acetoacetate. In support of the latter possibility is the finding that the activity of 3-hydroxybutyrate dehydrogenase in brain is less than one-quarter that of 3-oxo acid CoA-transferase .
In contrast to acetoacetate, the calculated concentration of 3-hydroxybutyrate in the extravascular space of brain bore little relationship to the concentration in blood; in fact, the calculated value for 3-hydroxybutyrate in the brain of starved rats was equal to or higher than that in diabetic animals (Table  6 ). Although the basis for this finding is not known, it may bear on the observation that the arteriovenous difference across the brain for 3-hydroxybutyrate was not significantly greater in rats with diabetic ketoacidosis than in starved rats (see Table 2 ).
Discussion
The data indicate that in diabetic ketoacidosis the uptake of glucose by brain of an anaesthetized rat is decreased, glycolysis is inhibited at phosphofructokinase and the uptake of ketone bodies is increased. Although it seems likely that the increase in brain ketone-body utilization is related to the elevated concentrations of acetoacetate and 3-hydroxybutyrate in blood (Hawkins et al., 1971; Daniel et al., 1971 ; the present study), the basis for the decrease in glucose metabolism is less clear. A possible explanation is (Table 2 ). In addition, the infusion of 3-hydroxybutyrate had no effect on the arteriovenous difference for glucose despite a substantial increase in the uptake of ketone bodies. These findings may be explained eventually by methodological difficulties in precisely determining the arteriovenous difference for glucose and/or by an artifact introduced by infusing DL-3-hydroxybutyrate; nevertheless, it must be stated at the present time that the evidence that an accelerated rate of ketone-body oxidation can by itself initiate inhibition of cerebral glycolysis at phosphofructokinase is inconclusive.
The evidence that an accelerated rate of ketonebody metabolism can lead to inhibition of oxidation of pyruvate and hence of glucose by brain is more substantial. In addition to the fact that there was a significant positive correlation between the arteriovenous differences for ketone bodies and lactate, infusion with 3-hydroxybutyrate caused a marked increase in lactate release, indicating inhibition of pyruvate oxidation. Once again, the analogy to the perfused heart is relevant, since Randle et al. (1966) found that pyruvate oxidation in this preparation is inhibited when ketone bodies or free fatty acids are added to the perfusate.
The conclusions of the present study are substantially in agreement with those ofearlier investigations in which the effects of ketone bodies on cerebral glucose and pyruvate metabolism were studied in slices of cerebral cortex (Ide et al., 1969; Itoh & Quastel, 1970; Rolleston & Newsholme, 1967) brain (Openshaw & Bortz, 1968) . In general, neither acetoacetate (Itoh & Quastel, 1970; Rolleston & Newsholme, 1967) nor 3-hydroxybutyrate (Rolleston & Newsholme, 1967) were found to diminish glucose uptake, although in one investigation, 3-hydroxybutyrate seemed to decrease the disappearance of [U-14C]glucose (Ide et al., 1969) . In contrast, ketone bodies invariably inhibited glucose oxidation, a finding which was explained by inhibition of pyruvate oxidation, rather than a block higher in the glycolytic pathway (Ide et al., 1969; Itoh & Quastel, 1970) . Itoh & Quastel (1970) proposed that this inhibition, like that found in heart muscle perfused with ketone bodies (Randle et al., 1966) (Siess et al., 1971) . A change in the acetyl-CoA/CoA ratio could have accounted for the decrease in pyruvate oxidation observed in the present study, since the concentration of acetyl-CoA was elevated in both starved and streptozotocin-treated rats, although in the latter group, the 6-fold increase in the arteriovenous difference for lactate was not statistically significant. Changes in the concentration of pyruvate dehydrogenase, or in the proportion of active and inactive enzyme, may also have been a factor, since Siess et al. (1971) have noted a 27% decrease in the activity of pyruvate dehydrogenase in rat brain after 48 h of starvation. Measurements of pyruvate dehydrogenase activity in the brains of diabetic rats have not been reported.
During starvation ketone bodies accounted for 20-25 % of the calculated 02 consumption of brain, and the arteriovenous difference for lactate was increased. Glucose oxidation was diminished by 21 % at 24h and by 33% at 48h of starvation. Although this compensated completely for the increment in calculated 02 consumption caused by ketone-body oxidation, these decreases in calculated glucose oxidation were not statistically significant. In all likelihood this was due to the variability of the measurements needed to calculate values for glucose oxidation, since the increase in the arteriovenous difference for ketone bodies was highly significant and the calculated arteriovenous difference for 02 was unchanged.
The fact that the arteriovenous difference for lactate was also significantly increased lends further support to this view.
The enzymic apparatus for ketone-body utilization in muscle and brain appear to be the same (Tildon & Sevdalian, 1972; Williamson et al., 1971) and in both tissues the magnitude of acetoacetate and 3-hydroxybutyrate uptake is a function primarily of their concentration in plasma (Hawkins et al., 1971; Daniel et al., 1971; . On the other hand, in a 48 h-starved rat the oxidation of ketone bodies can account for 77 % of the 02 consumption of muscle (Ruderman et al., 1971) , whereas it provides only 25% of the fuel needs of brain (Hawkins et al., 1971 ; the present paper). It is only in the diabetic rat, in which the concentrations of ketone bodies are 2-3-fold greater than those of the starved animal, that acetoacetate and 3-hydroxybutyrate comprise more than 40% of brain fuel. These findings probably reflect the fact that ketone bodies are able to diffuse freely into muscle and are therefore able to saturate 3-oxo acid CoA-transferase when their concentration in blood is relatively low , whereas the entrance ofketone bodies into brain is restricted (Table 6) , and, as a result, the concentrations of acetoacetate and 3-hydroxybutyrate in brain, at a given blood concentration, are much lower than in muscle. The high rates of ketone-body utilization reported for human brain (Owen et al., 1967) can be accounted for by the fact that during prolonged starvation man achieves much higher concentrations of ketone bodies in his circulation (Cahill et al., 1966; Owen et al., 1967) than does the rat (Hawkins et al., 1971) .
